Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.
about
Low-dose rate brachytherapy for men with localized prostate cancerRadical prostatectomy versus watchful waiting for prostate cancerEvaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis.The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databasesGeriatric considerations in the treatment of advanced prostate cancerUnscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease.Impact of age on the cancer-specific survival of patients with localized renal cell carcinoma: martingale residual and competing risks analysisVariation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancerImpact of age at diagnosis on prostate cancer treatment and survivalCharacteristics and experiences of patients with localized prostate cancer who left an active surveillance program.Follow-up Care Education and Information: Identifying Cancer Survivors in Need of More Guidance.Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling studyRadical Prostatectomy in Korean Men Aged 75-Years or Older: Safety and Efficacy in Comparison with Patients Aged 65-69 Years.Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.Challenges of managing elderly men with prostate cancer.Long term results of HDR brachytherapy in men older than 75 with localized carcinoma of the prostate.Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients.Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly menPatients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea
P2860
Q24235544-C4FB0940-1855-4316-918E-6E97527691E7Q24236564-6812C77F-C879-480B-9535-D016C9976336Q30405851-23E3AA67-9115-4837-8A23-204E302E4E90Q33516060-BBA4D23F-0D85-43E5-B23A-02EC74EB2FF2Q33598327-83EBDAF5-42A8-4BEF-AC75-4ACF088C0C40Q33676037-334BEBC9-B58A-49FE-AA16-2B36FBC0AC5BQ34465177-9E1C8B76-2B8E-4BAA-9E24-6E0263475E9EQ34550547-FDF3AD8C-4510-4F70-9973-BA5914479166Q34679220-5AFA8FD6-E63F-46C7-B730-F7591F709A11Q35095972-AC1DCAB4-F607-4167-8C9B-12548F5A2BDEQ35762955-546088F4-8E24-4AA2-B3F1-9DCE02F9DE64Q36274021-EFCD312B-19AE-4A36-BB6F-41D22C99F1B0Q36859908-89C1D1A8-B66B-468F-88B9-9D4543EB1FA1Q37594735-7A6ED0FD-1C4F-4E4A-AD36-5D6598A6BA08Q38211358-F70C6239-2C2D-4F2E-A2CA-7D1093FC8255Q42794326-785297BF-92DC-4AC6-86D1-E3C28B9EFE21Q44716909-E1A927E1-42EC-4B40-9DD9-CA30E2C7AA30Q52617229-28C3CF46-5B65-492D-9C24-FEC58A19F852Q57118155-982454CB-4A4A-4A8B-888D-50347DD540D1Q57224992-CCF58CEC-2CEE-4938-9AA3-7A0395E9662D
P2860
Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Patterns of primary and second ...... analysis of data from CaPSURE.
@ast
Patterns of primary and second ...... analysis of data from CaPSURE.
@en
type
label
Patterns of primary and second ...... analysis of data from CaPSURE.
@ast
Patterns of primary and second ...... analysis of data from CaPSURE.
@en
prefLabel
Patterns of primary and second ...... analysis of data from CaPSURE.
@ast
Patterns of primary and second ...... analysis of data from CaPSURE.
@en
P2093
P1476
Patterns of primary and second ...... analysis of data from CaPSURE.
@en
P2093
Badrinath R Konety
CaPSURE Investigators
Janet E Cowan
Peter R Carroll
P304
1797-803; discussion 1803
P356
10.1016/J.JURO.2008.01.044
P407
P577
2008-03-17T00:00:00Z